Cargando…

Effective impairment of myeloma cells and their progenitors by hyperthermia

Multiple myeloma (MM) remains incurable, and MM-initiating cells or MM progenitors are considered to contribute to disease relapse through their drug-resistant nature. In order to improve the therapeutic efficacy for MM, we recently developed novel superparamagnetic nanoparticles which selectively a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miki, Hirokazu, Nakamura, Shingen, Oda, Asuka, Tenshin, Hirofumi, Teramachi, Jumpei, Hiasa, Masahiro, Bat-Erdene, Ariunzaya, Maeda, Yusaku, Oura, Masahiro, Takahashi, Mamiko, Iwasa, Masami, Harada, Takeshi, Fujii, Shiro, Kurahashi, Kiyoe, Yoshida, Sumiko, Kagawa, Kumiko, Endo, Itsuro, Aihara, Kenichi, Ikuo, Mariko, Itoh, Kohji, Hayashi, Koichiro, Nakamura, Michihiro, Abe, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828190/ https://www.ncbi.nlm.nih.gov/pubmed/29535808 http://dx.doi.org/10.18632/oncotarget.23121

Ejemplares similares

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
por: Bat-Erdene, Ariunzaya, et al.
Publicado: (2016)

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
por: Teramachi, Jumpei, et al.
Publicado: (2020)

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ
por: Iwasa, Masami, et al.
Publicado: (2019)

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
por: Ashtar, Mohannad, et al.
Publicado: (2020)

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
por: Amachi, Ryota, et al.
Publicado: (2016)

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma
por: Watanabe, Keiichiro, et al.
Publicado: (2021)

Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma
por: Oura, Masahiro, et al.
Publicado: (2023)

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma
por: Tanimoto, Kotaro, et al.
Publicado: (2021)

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase
por: Harada, Takeshi, et al.
Publicado: (2022)

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
por: Hanson, Derek James, et al.
Publicado: (2015)

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
por: Nakaue, Emiko, et al.
Publicado: (2023)

Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis
por: Masuda, Shiho, et al.
Publicado: (2023)

Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis
por: Sumitani, Ryohei, et al.
Publicado: (2021)

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression
por: Tenshin, Hirofumi, et al.
Publicado: (2022)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
por: Higa, Yoshiki, et al.
Publicado: (2023)

Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling
por: Harada, Takeshi, et al.
Publicado: (2021)

Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava
por: Nakamura, Shingen, et al.
Publicado: (2017)

Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes
por: Yamagami, Hiroki, et al.
Publicado: (2023)

The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease
por: Miki, Hirokazu, et al.
Publicado: (2022)

Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer
por: Kondo, Takeshi, et al.
Publicado: (2016)

Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index
por: Mitsui, Yukari, et al.
Publicado: (2021)

Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review
por: Kurahashi, Kiyoe, et al.
Publicado: (2017)

TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
por: Takeuchi, Kyoko, et al.
Publicado: (2010)

Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors
por: Harada, Takeshi, et al.
Publicado: (2013)

The Role of Heparin Cofactor II in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice
por: Kurahashi, Kiyoe, et al.
Publicado: (2017)

Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
por: Hayashi, Koichiro, et al.
Publicado: (2013)

Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes
por: Yasui, Saya, et al.
Publicado: (2023)

Magnetically Responsive Smart Nanoparticles for Cancer Treatment with a Combination of Magnetic Hyperthermia and Remote-Control Drug Release
por: Hayashi, Koichiro, et al.
Publicado: (2014)

Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes
por: Hara, Tomoyo, et al.
Publicado: (2021)

Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL
por: Kagawa, Kumiko, et al.
Publicado: (2012)

Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
por: Hara, Tomoyo, et al.
Publicado: (2023)

Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma
por: Yamashita, Michiko, et al.
Publicado: (2015)

SUN-081 Eicosapentaenoic Acid Administration Ameliorates Cardiac Remodeling In Humans And Protects Against Ang Ii-induced Cardiovascular Remodeling Via Attenuation Of Oxidative Stress In Mice.
por: Yoshida, Sumiko, et al.
Publicado: (2019)

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
por: Mori, Hiroyasu, et al.
Publicado: (2019)

Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
por: Nakano, Ayako, et al.
Publicado: (2011)

Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma
por: Ozaki, Shuji, et al.
Publicado: (2019)

Developmental changes in mental rotation ability and visual perspective-taking in children and adults with Williams syndrome
por: Hirai, Masahiro, et al.
Publicado: (2013)

Typical visual search performance and atypical gaze behaviors in response to faces in Williams syndrome
por: Hirai, Masahiro, et al.
Publicado: (2016)

Preserved search asymmetry in the detection of fearful faces among neutral faces in individuals with Williams syndrome revealed by measurement of both manual responses and eye tracking
por: Hirai, Masahiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r365kri0pc1kpniql4p6o3bbok